NCT04514770

Brief Summary

Investigation the effect of timing of amniotomy (early versus delayed) after vaginal misoprostol in induced labor. Condition: induction of labour intervention: eary versus late amniotomy on labour induction after vaginal misoprostol Phase: Not applicable

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 17, 2020

Completed
Last Updated

August 17, 2020

Status Verified

August 1, 2020

Enrollment Period

8 months

First QC Date

July 28, 2020

Last Update Submit

August 12, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • successful induction

    definition of successful induction is occurrence of vaginal delivery within 24 hours from the beginning of induction

    immediately after intervention

  • induction-delivery interval

    duration of labor and amniotomy delivery interval

    immediately after intervention

Secondary Outcomes (5)

  • misoprostol doses administered

    during the intervention

  • the need for augmentation of labor

    during the intervention

  • intrapartum meconium

    during the intervention

  • Apgar score

    during the intervention

  • newborn admission in the neonatal intensive care unit

    immediately after intervention

Study Arms (2)

early amniotomy

ACTIVE COMPARATOR

Group A: 1. Pregnant women had taken misoprostol (vagiprost vaginal tablet; Adwia Pharmaceutical Company) vaginally as 25 micro gram of misoprostol. It was repeated every 6 hours until three or more uterine contractions of 40 second duration occur over 10 minutes, or when reaching four doses maximum (i.e. 100 micro gram) is reached. 2. Early amniotomy was performed for the participant of the first group at 3 cementer cervical dilatation with Kocher's forceps provided the head is well fitted to the cervix.

Drug: Misoprostol

Late amniotomy

ACTIVE COMPARATOR

Group B: 1. Pregnant women had taken misoprostol (vagiprost vaginal tablet; Adwia Pharmaceutical Company) vaginally as 25 micro gram of misoprostol. It was repeated every 6 hours until three or more uterine contractions of 40 second duration occur over 10 minutes, or when reaching four doses maximum (i.e. 100 micro gram) is reached. 2. late amniotomy was performed for the participant of the second group at 7 cementer cervical dilatation.

Drug: Misoprostol

Interventions

rupture of membrane early and late

Also known as: Amniotomy
Late amniotomyearly amniotomy

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsNulliparous Women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women at 36 weeks gestation or more
  • Nullipara
  • singleton fetus
  • cephalic presentation with common medical causes for labour induction e.g. intrauterine fetal growth restriction, post term pregnancy and preeclampsia.

You may not qualify if:

  • Macrocosmic babies with estimated fetal weight of more than 4000 gram
  • Previous uterine scars
  • Pre labor premature rupture of fetal membranes
  • Polyhydramnios.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Menoufia University hospital

Shibīn al Kawm, Menoufia, 11111, Egypt

Location

MeSH Terms

Interventions

MisoprostolAmniotomy

Intervention Hierarchy (Ancestors)

Prostaglandins E, SyntheticProstaglandins, SyntheticProstaglandinsEicosanoidsFatty Acids, UnsaturatedFatty AcidsLipidsAutacoidsInflammation MediatorsBiological FactorsLabor, InducedDelivery, ObstetricObstetric Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Group A: Early amniotomy was performed for the participant of the first group at 3 cm cervical dilatation with Kocher's forceps provided the head is well fitted to the cervix. Group B: late amniotomy was performed for the participant of the second group at 7 cm cervical dilatation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of obstetrics and gynecology

Study Record Dates

First Submitted

July 28, 2020

First Posted

August 17, 2020

Study Start

May 3, 2019

Primary Completion

January 10, 2020

Study Completion

March 20, 2020

Last Updated

August 17, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations